DocMorris AG
SIX:DOCM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
DocMorris AG
SIX:DOCM
|
CH |
DocMorris AG
DocMorris AG is an online pharmacy and health retailer. It sells prescription medicines, over-the-counter drugs, and everyday health and personal care products through its digital storefront, and it also offers related services such as prescription handling and pharmacy advice. The company mainly serves consumers and patients who want to buy medicines and health products without visiting a traditional brick-and-mortar pharmacy. Its money comes from selling medicines and health products, plus service revenue tied to pharmacy fulfillment and digital health services. In practice, DocMorris sits between drug makers, wholesalers, and end customers: it buys products, manages prescriptions and fulfillment, and delivers orders directly to patients. That makes it different from a normal retailer because a large part of its business depends on regulated pharmacy rules and prescription processing, not just standard online shopping. For beginner investors, the key idea is that DocMorris is a pharmacy business built around e-commerce and digital access. Its customers value convenience, delivery, and easier prescription management, while the company earns by turning pharmacy demand into an online service. The business model is closely tied to healthcare regulation and the everyday need for medicines, which gives it a clear role in the value chain.
DocMorris AG is an online pharmacy and health retailer. It sells prescription medicines, over-the-counter drugs, and everyday health and personal care products through its digital storefront, and it also offers related services such as prescription handling and pharmacy advice. The company mainly serves consumers and patients who want to buy medicines and health products without visiting a traditional brick-and-mortar pharmacy.
Its money comes from selling medicines and health products, plus service revenue tied to pharmacy fulfillment and digital health services. In practice, DocMorris sits between drug makers, wholesalers, and end customers: it buys products, manages prescriptions and fulfillment, and delivers orders directly to patients. That makes it different from a normal retailer because a large part of its business depends on regulated pharmacy rules and prescription processing, not just standard online shopping.
For beginner investors, the key idea is that DocMorris is a pharmacy business built around e-commerce and digital access. Its customers value convenience, delivery, and easier prescription management, while the company earns by turning pharmacy demand into an online service. The business model is closely tied to healthcare regulation and the everyday need for medicines, which gives it a clear role in the value chain.
Revenue: DocMorris said Q1 revenue grew 10.7% year over year, led by very strong Rx growth and rapid scaling in Digital Services.
Rx momentum: Rx sales rose 30.4% year over year and 7.6% sequentially, with management saying growth accelerated through March and continued into April.
Profitability path: Adjusted EBITDA improved by CHF 9.8 million year over year to minus CHF 6.3 million, and management reiterated that it expects EBITDA breakeven in 2026.
Guidance confirmed: The company reaffirmed its 2026 adjusted EBITDA target of minus CHF 10 million to minus CHF 25 million and said it remains confident even at the high end of revenue guidance.
Digital Services: Digital Services revenue grew 63.1%, and management said margins are improving as the business scales, with TeleClinic shifting toward better profitability.
Operating discipline: Management highlighted better marketing efficiency, lower customer acquisition costs, and cost savings from logistics closures as key drivers of the improved result.
